Editorial comment
- PMID: 21419442
- PMCID: PMC4731868
- DOI: 10.1016/j.juro.2010.12.107
Editorial comment
Comment on
-
Predictive factors for malignant pheochromocytoma: analysis of 136 patients.J Urol. 2011 May;185(5):1583-90. doi: 10.1016/j.juro.2010.12.050. Epub 2011 Mar 21. J Urol. 2011. PMID: 21419457
References
-
- Thompson LD. Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases. Am J Surg Pathol. 2002;26:551. - PubMed
-
- Strong VE, Kennedy T, Al-Ahmadie H, et al. Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis. Surgery. 2008;143:759. - PubMed
-
- Agarwal A, Mehrotra PK, Jain M, et al. Size of the tumor and pheochromocytoma of the adrenal gland scaled score (PASS): can they predict malignancy? World J Surg. 2010;34:3022. - PubMed
-
- Neumann HP, Bausch B, McWhinney SR, et al. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med. 2002;346:1459. - PubMed
-
- Amar L, Bertherat J, Baudin E, et al. Genetic testing in pheochromocytoma or functional paraganglioma. J Clin Oncol. 2005;23:8812. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
